GlobalData on MSN3d
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
STAT3d
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
Health.com6d
16 Gluten-Free Snacks To Keep You Satisfied
Healthy gluten-free snacks include popcorn, vegetables and hummus, nut butters, edamame, and gluten-free crackers. Nutrition ...